Author:
Bar-Zeev Naor,Moss William J
Reference11 articles.
1. The development of COVID-19 vaccines: safeguards needed;Lurie;JAMA,2020
2. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial;Folegatti;Lancet,2020
3. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial;Zhu;Lancet,2020
4. Clinical trials for COVID-19 should include sex as a variable;Bischof;J Clin Invest,2020
5. OpenSAFELY: factors associated with COVID-19 death in 17 million patients;Williamson;Nature,2020
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献